Characterizing participants in the North Carolina Breast and Cervical Cancer Control Program: A retrospective review of 90, 000 women. Issue 14 (7th April 2021)

• Record Type: Journal Article
• Authors: Tait, Sarah D.; Ren, Yi; Horton, Cushanta C.; Oshima, Sachiko M.; Thomas, Samantha M.; Wright, Sherry; Caesar, Awanya; Plichta, Jennifer K.; Hwang, E. Shelley; Greenup, Rachel A.; Rosenberger, Laura H.; DiLalla, Gayle D.; Menendez, Carolyn S.; Tolnitch, Lisa; Hyslop, Terry; Nelson, Debi; Fayanju, Oluwadamilola M.
• Is Part Of: Cancer. Volume 127:Issue 14(2021)
• Page Start: 2515
• Page End: 2524
• Publication Date: 2021-04-07
• Subjects: breast neoplasms -- cancer screening -- health care disparities -- insurance; Cancer -- Periodicals; Cancer -- Cytopathology -- Periodicals; 616.99405
• DOI: 10.1002/cncr.33473
• Languages: English
• ISSNs: 0008-543X

Abstract

Abstract : Background: The North Carolina Breast and Cervical Cancer Control Program (NC BCCCP) provides breast cancer screening services to underserved women to mitigate disparities in access to care. The authors sought to characterize this understudied population. Methods: Women 21 years old or older who underwent their first breast cancer screen through NC BCCCP from 2008 to 2018 were included. Demographic factors associated with the timeline of care and odds of a breast cancer diagnosis were identified with negative binomial and logistic regression, respectively. Results: Of the 88, 893 women identified, 45.5% were non‐Hispanic (NH) White, 30.9% were NH Black, 19.6% were Hispanic, 1.7% were American Indian, and 1.1% were Asian. Breast cancer was diagnosed in 2.5% of the women (n = 2255). Hispanic women were the least likely to be diagnosed with breast cancer (odds ratio vs NH White women, 0.40; 95% confidence interval [CI], 0.34‐0.47). Among patients with breast pathology, the median time to diagnosis was 19 days (interquartile range [IQR], 10‐33 days), and the time to treatment was 33 days (IQR, 19‐54 days). After adjustments, a longer time to diagnosis was significantly associated with age (incidence rate ratio [IRR], 1.01; 95% CI, 1.01‐1.02) and being NH Black (vs NH White; IRR, 1.17; 95% CI, 1.06‐1.29). A longer time to treatment was significantly associated with age (IRR, 1.01; 95% CI, 1.01‐1.01), being NH Black (vs NH White; IRR, 1.20; 95% CI, 1.10‐1.31), and being Hispanic (vs NH White; IRR, 1.22; 95% CI, 1.05‐1.41). Conclusions: NC BCCCP participants with breast cancer received treatment within approximately 1 month of presentation, and this finding aligns with quality care benchmarks. Nevertheless, racial/ethnic disparities in timeliness of care persist, and this suggests opportunities for improvement. Lay Summary: This review of approximately 90, 000 participants in a breast cancer screening program for uninsured and underinsured women highlights the importance of safety net programs in providing timely care to underserved patients. The authors found that the North Carolina Breast and Cervical Cancer Control Program met timeliness benchmarks from the Centers for Disease Control and Prevention across all racial/ethnic groups. However, non‐Hispanic Black women experienced relative delays in the time to diagnosis, and both non‐Hispanic Black women and Hispanic women experienced relative delays in the time to treatment. These findings demonstrate how racial/ethnic disparities in the timeliness of care can persist even within a program intended to reduce barriers to access. Abstract : This retrospective review of almost 90, 000 participants in a breast cancer screening program for uninsured and underinsured women highlights the importance of safety net programs in providing timely care to underserved patients. However, these findings also demonstrate that racial/ethnic disparities in timeliness of care persist even when insurance status is mitigated as a barrier to access.